Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Nike (NKE) Beats Stock Market Upswing: What Investors Need to Know
Nike (NKE) Beats Stock Market Upswing: What Investors Need to Know

Nike (NKE) ended the recent trading session at $54.79, demonstrating a +1.5% change from the preceding day's closing price. The stock exceeded the S&P 500, which registered a gain of 1.01% for the

ServiceNow (NOW) Surpasses Market Returns: Some Facts Worth Knowing
ServiceNow (NOW) Surpasses Market Returns: Some Facts Worth Knowing

In the latest close session, ServiceNow (NOW) was up +1.11% at $114.88. This move outpaced the S&P 500's daily gain of 1.01%. Meanwhile, the Dow gained 0.83%, and the Nasdaq, a tech-heavy index

Palantir Technologies Inc. (PLTR) Exceeds Market Returns: Some Facts to Consider
Palantir Technologies Inc. (PLTR) Exceeds Market Returns: Some Facts to Consider

Palantir Technologies Inc. (PLTR) closed the most recent trading day at $152.72, moving +1.17% from the previous trading session. The stock's change was more than the S&P 500's daily gain of 1.01%

ASML (ASML) Laps the Stock Market: Here's WhyPhoto, wide shot, wide-angle lens,  Software company, sunset photo at golden hour, photo by Marc Adamus: https://img.theapi.app/temp/9d624ad0-0157-4808-b12c-caf136345180.png
ASML (ASML) Laps the Stock Market: Here's Why

ASML (ASML) ended the recent trading session at $1,375.82, demonstrating a +2.24% change from the preceding day's closing price. This move outpaced the S&P 500's daily gain of 1.01%. Elsewhere, the

Amazon (AMZN) Rises Higher Than Market: Key Facts
Amazon (AMZN) Rises Higher Than Market: Key Facts

Amazon (AMZN) ended the recent trading session at $211.74, demonstrating a +1.96% change from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily gain of

DocGo Inc. (DCGO) Reports Q4 Loss, Beats Revenue Estimates
DocGo Inc. (DCGO) Reports Q4 Loss, Beats Revenue Estimates

DocGo Inc. (DCGO) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to earnings of $0.04 per share a year ago. These figures are

Dragonfly Energy Holdings Corp. (DFLI) Reports Q4 Loss, Beats Revenue Estimates
Dragonfly Energy Holdings Corp. (DFLI) Reports Q4 Loss, Beats Revenue Estimates

Dragonfly Energy Holdings Corp. (DFLI) came out with a quarterly loss of $4.57 per share versus the Zacks Consensus Estimate of a loss of $0.8. This compares to a loss of $10.1 per share a year ago

Natural Gas Services (NGS) Q4 Earnings Miss EstimatesPhoto, wide shot, wide-angle lens,  Coal company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.midjourneyapi.xyz/temp/2a011bdc-adca-4de9-8457-d868b31178cf.png
Natural Gas Services (NGS) Q4 Earnings Miss Estimates

Natural Gas Services (NGS) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.29 per share a year ago

Semtech (SMTC) Tops Q4 Earnings and Revenue Estimates
Semtech (SMTC) Tops Q4 Earnings and Revenue Estimates

Semtech (SMTC) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.4 per share a year ago. These figures are

Getty Images Holdings, Inc. (GETY) Reports Q4 Loss, Beats Revenue Estimates
Getty Images Holdings, Inc. (GETY) Reports Q4 Loss, Beats Revenue Estimates

Getty Images Holdings, Inc. (GETY) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of $0.05. This compares to a loss of $0.01 per share a year ago. These

Comtech Telecommunications (CMTL) Reports Q2 Loss, Lags Revenue EstimatesPhoto, wide shot, wide-angle lens,  Cable TV provider, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.midjourneyapi.xyz/temp/51ec7f0d-2b5e-41f6-baa4-43bf0f5d7e7d.png
Comtech Telecommunications (CMTL) Reports Q2 Loss, Lags Revenue Estimates

Comtech Telecommunications (CMTL) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.3. This compares to a loss of $0.35 per share a year ago

Assertio (ASRT) Reports Q4 Loss, Beats Revenue Estimates
Assertio (ASRT) Reports Q4 Loss, Beats Revenue Estimates

Assertio (ASRT) came out with a quarterly loss of $1.86 per share versus the Zacks Consensus Estimate of a loss of $3.05. This compares to a loss of $1.65 per share a year ago. These figures are

Silvercrest (SAMG) Lags Q4 Earnings Estimates
Silvercrest (SAMG) Lags Q4 Earnings Estimates

Silvercrest (SAMG) came out with quarterly earnings of $0.18 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.2 per share a year ago. These figures

Top Research Reports for Philip Morris, Lam Research & Goldman Sachs
Top Research Reports for Philip Morris, Lam Research & Goldman Sachs

Monday, March 16, 2026The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Philip Morris

Top Stock Picks for Week of March 16, 2026Photo, wide shot, wide-angle lens,  Software company, sunset photo at golden hour, photo by Marc Adamus: https://img.theapi.app/temp/9d624ad0-0157-4808-b12c-caf136345180.png
Top Stock Picks for Week of March 16, 2026

Nebius Group N.V.'s (NBIS) core business is Nebius, an AI-centric cloud platform built for intensive AI workloads. Nebius builds full-stack infrastructure for AI, including large-scale GPU clusters

These Dividend Monsters Continue to Outshine the Market: PEP, HSYPhoto, wide shot, wide-angle lens,  Semiconductor company, sunset photo at golden hour, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/92ce44e9-64c7-4458-9a95-b706ed510490.png
These Dividend Monsters Continue to Outshine the Market: PEP, HSY

Amid the continued AI craze in 2026, many have overlooked simple businesses that aren’t overly flashy, such as well-established companies like Hershey HSY, and PepsiCo PEP, both of which have nicely

Micron to Report Q2 Earnings: Buy, Hold, or Take Profits Now?
Micron to Report Q2 Earnings: Buy, Hold, or Take Profits Now?

Micron Technology, Inc. MU is all set to release its highly anticipated fiscal second-quarter 2026 results after the market closes on March 18. As in previous quarters, the report will provide key

SCHW Stock Up On Solid Q1 Revenue View, Higher February Client Assets
SCHW Stock Up On Solid Q1 Revenue View, Higher February Client Assets

Shares of Charles Schwab SCHW have gained 2% on Friday in response to upbeat revenue guidance for the first quarter of 2026. The company reported an increase in total client assets for February.

Is Tesla Expanding Beyond EVs Into Energy Supply in UK?
Is Tesla Expanding Beyond EVs Into Energy Supply in UK?

Tesla TSLA has obtained approval from the UK energy regulator Ofgem to supply electricity directly to households and businesses across Great Britain, expanding its presence in the country’s energy

Venture Global Reaches FID and Secures $8.6B for CP2 LNG Phase 2Photo, wide shot, wide-angle lens,  Coal company, neutral atmosphere, photo by Galina Stepanova: https://img.theapi.app/temp/0e838f13-fa33-4583-92e9-bf3375dacf70.png
Venture Global Reaches FID and Secures $8.6B for CP2 LNG Phase 2

Venture Global, Inc. VG, a U.S.-based liquefied natural gas (LNG) exporter, announced that it has reached a final investment decision (FID) for the second phase of its third LNG project, CP2 LNG, in

Here's Why Genpact Stock Is a Compelling Pick for You Right Now
Here's Why Genpact Stock Is a Compelling Pick for You Right Now

Genpact Limited G is benefiting from its strength in business process outsourcing (BPO) services, supported by its domain expertise in business analytics, and digital and consulting services.

Rivian Unveils R2 SUV Lineup With Pricing and Rollout TimelinePhoto, wide shot, wide-angle lens, soft focus,  Car rental company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-C39HK7mRtkD4E8dIGhNKdJKJ.png?st=2023-05-14T13%3A30%3A04Z&se=2023-05-14T15%3A30%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-13T20%3A57%3A44Z&ske=2023-05-14T20%3A57%3A44Z&sks=b&skv=2021-08-06&sig=c7kEiWtHt1KibrlL7jP9uEmEuV%2BuAnv1nRBACXoedSk%3D
Rivian Unveils R2 SUV Lineup With Pricing and Rollout Timeline

Rivian Automotive RIVN has announced the complete trim lineup and pricing for its upcoming R2 mid-size electric SUV, providing details about configurations, features and availability. The model is

Here's Why You Should Hold DexCom Stock in Your Portfolio for Now
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the continuous glucose monitoring (CGM) market. A strong fourth-quarter 2025

The Iran Storm Bypasses China: Why Its ETFs Look Attractive NowPhoto, wide shot, wide-angle lens,  Home appliance manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/5d70b6df-fa9b-4237-9702-39c36cb1d4f8.png
The Iran Storm Bypasses China: Why Its ETFs Look Attractive Now

Recent economic data released by China’s National Bureau of Statistics (“NBS”) reveal that the nation’s economy has delivered an unexpectedly solid start to 2026. Notably, retail sales rose 2.8%

PFE vs BMY: Which Large Oncology Drugmaker Is a Better Pick Now?Photo, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
PFE vs BMY: Which Large Oncology Drugmaker Is a Better Pick Now?

Pharma/biotech giants Pfizer PFE and Bristol Myers BMY boast a dominant position in the lucrative oncology space.

Oncology or cancer is one of the most sought-after areas in the pharma/biotech